Brain wave test may Fine-Tune Parkinson's stimulation
NCT ID NCT07485621
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether recording brain signals (called local field potentials) can help doctors pick the best deep brain stimulation (DBS) contacts for people with Parkinson's disease. About 40 participants will have these recordings done during routine care. The goal is to see if the signal-based choice matches the one doctors make using standard methods.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more data-driven way to select DBS settings, potentially improving symptom control for Parkinson's patients.
- What could go wrong
- This is a small observational study, not a treatment trial. It only checks if LFP recordings match clinical choices, not if they improve outcomes. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Mar 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with Parkinson's disease who are eligible for deep brain stimulation to treat refractory motor symptoms.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Voluntary written informed consent of the participant 2. At least 18 years of age at the time of signing the Informed Consent Form (ICF) 3. Diagnosis of idiopathic Parkinson's disease according to the clinical diagnostic criteria of the Movement Disorder Society (MDS) 4. Eligible for DBS to treat refractory PD motor symptoms, as based on multidisciplinary DBS screening 5. Have sufficient understanding of the Dutch and French language to participate in the study Exclusion Criteria: * /
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson's disease (PD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Hospitals Leuven
RECRUITINGLeuven, Vlaams-Brabant, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sharper brain scans could reveal Parkinson's changes sooner
- Leg cuffs plus walking: a new way to steady Parkinson's balance?
- Can brain stimulation be tuned to improve sleep in Parkinson's?
- Can a blood bank unlock the genetics of brain disease?
- Sleep disorder may hold the key to spotting Parkinson's years earlier
- Can a gentle brain zapping schedule ease Parkinson's symptoms?